Reference health

Tetracycline use in treating osteoarthritis: a systematic review

https://doi.org/10.1007/s00011-021-01435-4
CiteStamped reference-health badge
59/59 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

8 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 59 checked references that resolve
resolves10.1016/j.joca.2012.11.012
Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!)
resolves10.1002/jor.24457
Role of Inflammation and the Immune System in the Progression of Osteoarthritis
resolves10.1111/cod.12868
9‐<i>cis</i>‐<scp>R</scp>etinoic acid induces a distinct regulatory dendritic cell phenotype that modulates murine delayed‐type allergy
resolves10.1186/s13075-019-1923-x
Synovial fluid biomarkers associated with osteoarthritis severity reflect macrophage and neutrophil related inflammation
resolves10.1002/art.39006
Soluble Macrophage Biomarkers Indicate Inflammatory Phenotypes in Patients With Knee Osteoarthritis
resolves10.1002/art.27475
Chondrocyte innate immune myeloid differentiation factor 88–dependent signaling drives procatabolic effects of the endogenous toll‐like receptor 2/toll‐like receptor 4 ligands low molecular weight hyaluronan and high mobility group box chromosomal protein 1 in mice
resolves10.1002/art.22042
Increase in production of matrix metalloproteinase 13 by human articular chondrocytes due to stimulation with S100A4: Role of the receptor for advanced glycation end products
resolves10.1186/ar2917
S100A8 and S100A9 in experimental osteoarthritis
resolves10.1016/j.joca.2018.08.005
Biomarkers of inflammation – LBP and TLR— predict progression of knee osteoarthritis in the DOXY clinical trial
resolves10.1016/j.bbapap.2011.06.020
Proteases involved in cartilage matrix degradation in osteoarthritis
resolves10.1002/art.27582
Attenuation of osteoarthritis progression by reduction of discoidin domain receptor 2 in mice
resolves10.1016/j.joca.2018.01.017
Molecular influence of anterior cruciate ligament tear remnants on chondrocytes: a biologic connection between injury and osteoarthritis
resolves10.1002/art.34453
Osteoarthritis: A disease of the joint as an organ
resolves10.3390/cells8090984
The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma
resolves10.1111/j.1749-6632.2011.06354.x
The history of the tetracyclines
resolves10.1016/j.phrs.2018.07.002
Minocycline as a promising therapeutic strategy for chronic pain
resolves10.1002/14651858.CD007323.pub3
Doxycycline for osteoarthritis of the knee or hip
resolves10.1016/j.phrs.2011.06.010
The road forward: The scientific basis for tetracycline treatment of arthritic disorders
resolves10.1002/1529-0131(199906)42:6<1140::AID-ANR10>3.0.CO;2-7
Specificity of inhibition of matrix metalloproteinase activity by doxycycline: Relationship to structure of the enzyme
resolves10.1002/1529-0131(199904)42:4<719::AID-ANR15>3.0.CO;2-T
Differential patterns of response to doxycycline and transforming growth factor ?1 in the down-regulation of collagenases in osteoarthritic and normal human chondrocytes
resolves10.1371/journal.pone.0174853
Differential inhibition of activity, activation and gene expression of MMP-9 in THP-1 cells by azithromycin and minocycline versus bortezomib: A comparative study
resolves10.1128/AAC.40.4.934
The tetracycline derivative minocycline differentially affects cytokine production by monocytes and T lymphocytes
resolves10.1073/pnas.93.24.14014
A novel mechanism of action of tetracyclines: Effects on nitric oxide synthases
resolves10.1007/PL00000263
Tetracyclines inhibit nitrosothiol production by cytokine-stimulated osteoarthritic synovial cells
resolves10.1002/jor.21026
In vitro inhibition of aggrecanase activity by tetracyclines and proteoglycan loss from osteoarthritic human articular cartilage
resolves10.1016/j.joca.2012.11.010
Effects of doxycycline on mesenchymal stem cell chondrogenesis and cartilage repair
resolves10.1186/1746-6148-9-68
Injectable hyaluronic-acid-doxycycline hydrogel therapy in experimental rabbit osteoarthritis
resolves10.1002/jbm.b.33303
<scp><i>I</i></scp><i>n vitro</i> and <i>in vivo</i> evaluation of doxycycline‐chondroitin sulfate/<scp>PCL</scp>microspheres for intraarticular treatment of osteoarthritis
resolves10.1002/art.1780351007
Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline
resolves10.5402/2012/182097
An Assessment of the Chondroprotective Effects of Intra-Articular Application of Statin and Tetracycline on Early-Stage Experimental Osteoarthritis
resolves10.1016/j.mri.2011.09.025
Imaging longitudinal changes in articular cartilage and bone following doxycycline treatment in a rabbit anterior cruciate ligament transection model of osteoarthritis
resolves10.1177/08959374980120012001
The Potential Role of Doxycycline in the Treatment of Osteoarthritis of the Temporomandibular Joint
resolves10.1002/art.21122
Effects of doxycycline on progression of osteoarthritis: Results of a randomized, placebo‐controlled, double‐blind trial
resolves10.1136/ard.2010.147967
The effects of doxycycline on reducing symptoms in knee osteoarthritis: results from a triple-blinded randomised controlled trial
resolves10.1097/RHU.0000000000000095
Pilot Open Observations on Doxycycline Treatment for Erosive Osteoarthritis of the Hand
resolves10.7326/0003-4819-122-2-199501150-00001
Minocycline in Rheumatoid Arthritis: A 48-Week, Double-Blind, Placebo-Controlled Trial
resolves10.1002/art.1780400510
Treatment of early Rheumatoid Arthritis with minocycline or placebo. Results of a Randomized, double‐blind, placebo‐controlled trial
resolves10.1002/1529-0131(199908)42:8<1691::AID-ANR18>3.0.CO;2-S
Treatment of early seropositive rheumatoid arthritis with minocycline: Four-year followup of a double-blind, placebo-controlled trial
resolves10.1002/1529-0131(200110)44:10<2235::AID-ART385>3.0.CO;2-A
Treatment of early seropositive rheumatoid arthritis: A two-year, double-blind comparison of minocycline and hydroxychloroquine
resolves10.4085/1062-6050-51.5.08
Epidemiology of Posttraumatic Osteoarthritis
resolves10.1056/NEJMoa0800777
Incidental Meniscal Findings on Knee MRI in Middle-Aged and Elderly Persons
resolves10.1249/MSS.0000000000002161
Dysregulated Inflammatory Response Related to Cartilage Degradation after ACL Injury
resolves10.1016/j.joca.2013.11.002
Pro-inflammatory stimulation of meniscus cells increases production of matrix metalloproteinases and additional catabolic factors involved in osteoarthritis pathogenesis
resolves10.1002/art.11326
The release of crosslinked peptides from type II collagen into human synovial fluid is increased soon after joint injury and in osteoarthritis
resolves10.1136/ard.2011.150953
Why should we expect a structure-modifying osteoarthritis drug to relieve osteoarthritis pain?
resolves10.1002/art.37987
Magnetic Resonance Imaging–Based Three‐Dimensional Bone Shape of the Knee Predicts Onset of Knee Osteoarthritis: Data From the Osteoarthritis Initiative
resolves10.1186/ar3845
Early diagnosis to enable early treatment of pre-osteoarthritis
resolves10.1007/s11420-011-9241-0
MR Imaging Tools to Assess Cartilage and Joint Structures
resolves10.4103/1673-5374.206633
Minocycline targets multiple secondary injury mechanisms in traumatic spinal cord injury
resolves10.1186/1744-8069-7-88
The Contribution of Spinal Glial Cells to Chronic Pain Behaviour in the Monosodium Iodoacetate Model of Osteoarthritic Pain
resolves10.1186/1741-7015-11-200
So depression is an inflammatory disease, but where does the inflammation come from?
resolves10.1016/j.biopsych.2017.08.005
Elevated Translocator Protein in Anterior Cingulate in Major Depression and a Role for Inflammation in Suicidal Thinking: A Positron Emission Tomography Study
resolves10.1007/s11126-019-09707-3
Minocycline for Depressive Symptoms: a Meta-Analysis of Randomized, Double-Blinded, Placebo-Controlled Trials
resolves10.1038/s41398-019-0556-9
Minocycline alters behavior, microglia and the gut microbiome in a trait-anxiety-dependent manner
resolves10.1093/eurheartj/eht420
Early short-term doxycycline therapy in patients with acute myocardial infarction and left ventricular dysfunction to prevent the ominous progression to adverse remodelling: the TIPTOP trial
resolves10.1016/j.phrs.2011.05.002
Matrix metalloproteinase inhibition with tetracyclines for the treatment of coronary artery disease
resolves10.1016/j.anaerobe.2017.12.011
An in vitro study to assess the impact of tetracycline on the human intestinal microbiome
resolves10.1016/j.envint.2019.104989
Low-dose tetracycline exposure alters gut bacterial metabolism and host-immune response: “Personalized” effect?
The 8 references without a DOI — listed, not checked
no DOI — not checkedGreenwald RA, Golub LM, Lavietes B, Ramamurthy NS, Gruber B, Laskin RS, et al. Tetracyclines inhibit human synovial collagenase in vivo and in vitro. J Rheumatol. 1987;14:28–32.
no DOI — not checkedYu LP Jr, Smith GN Jr, Hasty KA, Brandt KD. Doxycycline inhibits type XI collagenolytic activity of extracts from human osteoarthritic cartilage and of gelatinase. J Rheumatol. 1991;18:1450–2.
no DOI — not checkedSmith GN Jr, Yu LP Jr, Brandt KD, Capello WN. Oral administration of doxycycline reduces collagenase and gelatinase activities in extracts of human osteoarthritic cartilage. J Rheumatol. 1998;25:532–5.
no DOI — not checkedShlopov BV, Stuart JM, Gumanovskaya ML, Hasty KA. Regulation of cartilage collagenase by doxycycline. J Rheumatol. 2001;28:835–42.
no DOI — not checkedKloppenburg M, Breedveld FC, Miltenburg AM, Dijkmans BA. Antibiotics as disease modifiers in arthritis. Clin Exp Rheumatol. 1993;11(Suppl 8):S113–5.
no DOI — not checkedPardy CK, Matyas JR, Zernicke RF. Doxycycline effects on mechanical and morphometrical properties of early- and late-stage osteoarthritic bone following anterior cruciate ligament injury. J Appl Physiol. 1985;2004(97):1254–60.
no DOI — not checkedStone M, Fortin PR, Pacheco-Tena C, Inman RD. Should tetracycline treatment be used more extensively for rheumatoid arthritis? Metaanalysis demonstrates clinical benefit with reduction in disease activity. J Rheumatol. 2003;30:2112–22.
no DOI — not checkedGossage DL, Cieslarova B, Ap S, Zheng H, Xin Y, Lal P, et al. Phase 1b study of the safety, pharmacokinetics, and disease-related outcomes of the matrix metalloproteinase-9 inhibitor andecaliximab in patients with rheumatoid arthritis. Clin Ther. 2018;40(156–165):e5.
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1007/s00011-021-01435-4"><img src="https://citestamp.com/citestamped/10.1007/s00011-021-01435-4/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1007/s00011-021-01435-4/badge.svg)](https://citestamp.com/citestamped/10.1007/s00011-021-01435-4)